Avosentan reduces albuminuria when added to standard treatment in people with type 2 diabetes and overt nephropathy but induces significant fluid overload and congestive heart failure
is potent and selective pan-RAF inhibitor with potential anticancer activity
Twenty-four hours after po administration
Hausheer FH
Inhibits interaction of SARS-CoV S protein and Vero E6 cells in vitro
Pedunculoside 3002 Avosentan reduces albuminuria when addedPedunculoside exerts lipid lowering effects partly through the regulation of lipogenesis and fatty acid oxidation. Product information CAS Number: 42719 32 4 Molecular Weight: 650. 84 Formula: C36H58O10 Chemical Name: (2S,3R,4S,5S,6R) 3,4,5 trihydroxy 6 (hydroxymethyl)oxan 2 yl (1R,2R,4aS,6aS,6bR,8aR,9R,10S,12aR,12bR,14bS) 8a,12b,14b trihydrogenio 1,10 dihydroxy 9 (hydroxymethyl) 1,2,6a,6b,9,12a hexamethyl